Recruiting NCT07012668
Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Interventional or surgical treatment, Interventional or surgical treatment.
- Who it may be relevant to
- Registry conditions: Neuro-co-cardiological Diseases, Post-cardiac Surgery Cerebrovascular Diseases, Vascular Lesion. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The objective of this observational cohort study is to evaluate the clinical outcomes of various treatment strategies for cerebrovascular and cardiovascular diseases. Furthermore, it aims to investigate the factors that influence adverse outcomes from these treatments.
Interventions
- Procedure Interventional or surgical treatment
Simultaneous interventional or surgical treatment/staged interventional or surgical treatment - Procedure Interventional or surgical treatment
Interventional or surgical treatment
Primary outcome measures
- Modified Rankin Scale Score [Time frame: 90±7 days]
Secondary outcome measures (7)
- Modified Rankin Scale Score [Time frame: 7±1 days or the day discharged]
- Modified Rankin Scale Score [Time frame: 365±30 days]
- Perioperative complication rate [Time frame: 30±7 days]
- Rate of cardiovascular and cerebrovascular events [Time frame: 90±7 days]
- Rate of cardiovascular and cerebrovascular events [Time frame: 365±30 days]
- Short-term complications [Time frame: 90±7 days]
- Long-term complications [Time frame: 365±30 days]
Eligibility criteria
Inclusion criteria
- Age ≥18 years;
- Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.
Exclusion criteria
- The expected survival is less than 1 years;
- Simultaneously merge other serious diseases;
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Beijing Anzhen Hospital — Beijing
Identifiers
NCT: NCT07012668 · ANGEL-NEUROCARD